Skip to main content
. 2021 Nov 11;23(12):1252–1260. doi: 10.1016/j.neo.2021.11.003

Fig. 1.

Fig 1

Immunophenotyping of TILs from AML patient BM samples (A) Representative FACS plots screening 6 AML patient BM samples; (B) Aggregate FACS data showing the percentage of CD3+ cells; (C) Aggregate FACS data showing the percentage of PD1+CD3+ cells. * P < 0.05.